Clinical Trials Browser

OTHER × Rectal Neoplasms × vandetanib × Clear all

NCT00532909 2012-07-16

Phase I Vandetanib Plus Capecitabine, Oxaliplatin and Bevacizumab for Metastatic Colorectal Cancer

Phase 1 Completed

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms